Importance: Expected outcomes from endokeratoplasty may vary with surgeon experience.
INTRODUCTION
Corneal transplantation has undergone a revolution over the past 15 years. A lamellar procedure has replaced penetrating keratoplasty as the procedure of choice for many indications for graft. Endothelial keratoplasty is now widely used in the treatment of disorders affecting the corneal endothelium. 1 An endothelial graft offers potential advantages over traditional full-thickness keratoplasty but may also be subject to a range of technique-specific complications, including the risks of graft detachment and early graft failure. [1] [2] [3] [4] [5] [6] A factor often cited as influencing the outcome of endothelial keratoplasty is the surgeon learning curve. 7 For a surgical procedure, the learning curve represents the time and experience that a surgeon requires to achieve an optimal level of competence with the new technique. 8 Increasing competence may be reflected in a reduction in the frequency of adverse events, a decrease in the time taken to complete the procedure or both. The learning curve no longer exerts an effect when surgeon skill, as reflected by procedure times and outcomes, reach a plateau. The learning curve for any surgical procedure may be affected by case complexity and characteristics of individual training environments, 7 which can vary greatly.
We have previously found no evidence for an individual surgeon learning curve for Descemet stripping endothelial keratoplasty (DSEK) and Descemet stripping automated endothelial keratoplasty (DSAEK) in Australia. 9 However, we examined outcomes achieved by a relatively small group of experienced and high-volume surgeons who were early adopters of endokeratoplasty and did not investigate the possibility that an overarching group learning curve, reflecting the combined experiences of all those undertaking the procedure (including less experienced, low-volume surgeons) might exist. Here, we sought evidence for an overarching surgeon learning curve in a large, multicentre, national cohort of endothelial keratoplasties.
METHODS
The operations of the Australian Corneal Graft Registry (ACGR), a national, prospectively followed cohort of over 32 000 corneal transplantations performed in Australia since May 1985, are approved by the Institutional Clinical Ethics Committee of Flinders University and are carried out in accordance with the Declaration of Helsinki. Data definition and collection are described in detail elsewhere. 9, 10 Records of 3065 endothelial grafts in 2767 eyes of 2433 recipients, performed between January 2006 and December 2013 and registered before April 2016, were examined. Descemet membrane endothelial keratoplasties (n = 411) and ultrathin DSEKs (n = 9) were excluded from analysis. Individual surgeon identity was missing in 31 instances, and these records were also excluded. No other exclusions were made, and a cohort of 2615 DSEKs and DSAEKs performed by 85 surgeons in 2139 recipients was thus available for combined analysis.
For each surgeon, grafts were sorted in date order and numbered sequentially.
Statistical analyses
The primary outcome measure was graft survival/failure. Graft failure was defined as oedema and loss of clarity in a previously thin, optically transparent graft or irremediable astigmatism. Primary graft non-function (PNF) was defined as a graft that never cleared in the immediate postoperative period. Any eye that was regrafted was classified as having a previous graft failure, regardless of the reason. For failed grafts, survival time was calculated as the number of days between the date of graft and the date of failure or regraft. For grafts surviving at last follow-up, survival time was calculated as the number of days between the date of graft and the date the patient was last seen by the surgeon. Occurrence of graft detachment, PNF or subsequent graft failure from any cause was as reported by the contributing surgeon. Grafts that detached in the immediate postoperative period and could not be successfully reattached within 3 months were included with PNFs.
Analyses were conducted in SPSS version 22 (IBM Corp, Armonk, NY, USA) and STATA version 11 (Stata, College Station, Texas, USA). Pearson chisquared analyses were performed to determine whether groups of grafts differed significantly in frequency of detachment or PNF. Continuity correction was used for 2 × 2 tests, and statistical significance was set at P < 0.05 (two-sided) with Bonferroni adjustment for multiple comparisons on the same data. Kaplan-Meier survival analyses were conducted to examine longitudinal graft survival. [11] [12] [13] Significance was assessed by the log-rank test. Variables identified as potentially significant (P < 0.08) in univariate analysis were included in a multivariate Cox proportional hazards regression analysis. 14 The final model included variables with a P value of <0.05. For categorical variables, a global test was applied to calculate the overall P value. Variables were eliminated in a stepwise manner, beginning with the least significant variable, until all remaining variables contributed significantly to the model. These analyses were clustered by patient, 15 and where the assumption of proportional hazards was violated, variables were treated as time variant.
RESULTS

Cohort and indications for graft
Records of 2615 DSEK and DSAEKs performed in 2360 eyes of 2139 recipients (range one to five grafts per recipient, one to four grafts per eye) registered by 85 surgeons were available for analysis. The median number of grafts registered by a single surgeon was 10 (range 1-315). The indications for graft are shown in Table 1 .
Evidence for a learning curve: graft sequence First, we examined whether survival of endothelial grafts varied according to surgeon experience with the technique of DSEK/DSAEK, as assessed by graft sequence. Data from individual surgeons were pooled in tranches (sequential groups) of 10 consecutive grafts, to investigate whether there was any evidence for a group learning curve. Hierarchical Bonferroni adjustments were made for multiple comparisons. Further comparisons were then made to determine the point at which the difference became non-significant. No significance differences in graft survival were observed, once 56 or more DSEKs/DSAEKs had been performed: performing additional grafts thereafter did not result in improved graft survival (Table 2) . Thus, the 'tipping point' was fewer than 57 grafts: below this number, survival was significantly poorer for early grafts performed by surgeons, as exemplified in Figure 1 , in which survival of grafts up to and including the 56th graft (14) ; congenital glaucoma, Descemet membrane detachment post cataract surgery, microbial keratitis, primary endotheliopathy, Rieger's anomaly, toxic anterior segment syndrome, unspecified endothelial dystrophy (one case each). Survival of endothelial grafts varied according to surgeon experience with the techniques of Descemet stripping endothelial keratoplasty and Descemet stripping automated endothelial keratoplasty, analysed together, and as assessed by graft survival, in tranches of 10, and then further specific tranches. Tranche A was compared with tranche B. *Significant before, but not after, Bonferroni adjustment (P < 0.05).
**Significant before and after Bonferroni adjustment. was compared with survival of grafts with a sequence number of more than 56 (χ 2 = 8.83, df = 1, P = 0.003). Similar findings were found for lesser numbers of grafts (graphs not shown).
Influence of surgeon workload
Based on the results relating to graft sequence outlined earlier, the impact of surgeon workload on graft survival was examined by comparing outcomes for 13 of 85 surgeons (15%) with 57 or more registered DSEKs and DSAEKs in the 8-year study period (high-volume surgeons), with those of surgeons with 56 or fewer such grafts during this period (low-volume surgeons) (Fig. 2) . Surgeons with higher workload achieved significantly better graft survival (χ 2 = 31.25, df = 1, P < 0.001).
Individual high-volume surgeon outcomes
Thirteen individual surgeons had registered more than 56 grafts. Figure 3 shows graft survival achieved by these surgeons, with procedures performed by surgeons with 56 or fewer grafts analysed together (χ 2 = 100.90, df = 13, P < 0.001). Nine high-volume surgeons had performed sufficient grafts (76+) with adequate follow-up (>80%) to perform individual comparisons on their first 56 grafts and the remainder (20+ grafts). Just one of these comparisons showed statistically significantly different survival between tranches of grafts (P = 0.048), however, this was in favour of the 56 grafts performed earlier in the surgeon's career (range of P values for other surgeons: 0.20 to 0.92).
Adverse events: graft detachment and primary non-functioning grafts Graft detachment was reported for 142 (5.4%) grafts. Grafts that had detached were significantly more likely to fail than those for which this complication was not reported (χ 2 = 46.40, df = 1, P < 0.001). There were no significant differences in the frequency of detachment between the first 56 grafts performed by individual surgeons and those in the sequence after 56 (5.4% vs. 5.5%, p = 1.00). PNF was reported for 150 (5.7%) grafts and occurred in 19.0% of grafts that had detached. There was a significant difference in the frequency of PNF between the first 56 grafts performed by individual surgeons and later grafts (χ 2 = 14.87, df = 1, P < 0.001). PNF was significantly less likely to have been reported for grafts performed by surgeons with more than 56 registered DSEKs and DSAEKs, compared with those with 56 or fewer grafts (4.3% vs. 8.5%; χ 2 = 18.38, df = 1, P < 0.001). However, PNF grafts did not occur significantly more frequently in the first 56 grafts when only data from high-volume surgeons (57+ grafts) were analysed (χ 2 = 3.71, df = 1, P = 0.054).
Multivariate analysis
Multivariate analysis was undertaken to investigate independent risk factors for failure of DSEKs and DSAEKs. Table 3 shows the variables considered for inclusion in the multivariate analyses and the point at which excluded variables were eliminated. Table 4 shows the final model derived (χ 2 = 189.72, P < 0.0001). The effects of graft era, graft dislocation, use of steroids pregraft and surgeon volume were time variant. The model included data from 2356 grafts for which information on all included variables had been provided.
DISCUSSION
The learning curve for new surgical procedures, the number of cases that need to be performed by a surgeon before he or she achieves predictable and stable results, 8 is well documented in a wide variety of fields. [16] [17] [18] [19] [20] The newer endothelial keratoplasty techniques such as DSEK and DSAEK are regarded as having a particularly steep learning curve, an issue often cited in studies assessing outcomes after surgery. 5, 7 However, the documented evidence for this learning curve is inconclusive, with mixed results reported. 6, 7, 21 We investigated graft outcomes for DSEKs and DSAEKs performed by all 85 ophthalmic surgeons who contribute records of these procedures to a national registry of keratoplasties and found some evidence to support a learning curve, especially for low-volume practitioners. Amalgamated at a national level, once surgeons had performed more than 56 grafts, survival did not improve significantly thereafter. However, we found little evidence to support the existence of an individual learning curve for the very high-volume practitioners.
We considered two key elements in our exploration of a potential learning curve: which outcome measure might be most appropriate to investigate, and how might the data best be analysed? Analyses of learning curves in other surgical disciplines have tended to focus on the length of time it takes to complete a surgery and the outcome of the procedure measured in terms of 'success'. 8, 22 The ACGR is an outcomes-focused registry and does not collect data on length of surgery. We thus focused on graft survival as the primary outcome measure, with specified Survival of endokeratoplasties may be affected by technical issues at surgery, which will be reflected in rates of graft detachment and primary graft failure, or longitudinally, as reflected in extended graft survival. A comparative analysis performed at a single time point will not take into account any later impact of surgeon skill on survival. Although most analyses of surgeon learning curves reported in the literature focus on a binary evaluation of success or failure, [23] [24] [25] [26] a requirement for many analytical techniques such as cumulative sum analysis, 27 the complex nature of data captured in a longitudinal registry required additional methods. Furthermore, previous analysis has shown the significant impact that many factors may play in the extended survival of corneal grafts. 9 Consequently, we sought to develop a methodology that would enable us to evaluate the impact of surgeon experience on both immediate and longitudinal graft survival, while controlling for additional significant influences on the latter.
Many studies split their cases into cohorts of arbitrary size, based on total numbers analysed, date of data collection or other external factors.
2,26,28-32 In selecting our analyses, we sought to allow the data to indicate the length of learning curve, rather than simply exploring comparisons between groups of grafts based on arbitrary levels of surgeon experience. By exploring the relationship between graft survival and surgeon experience in progressive groups of 10 grafts and then narrowing the analyses down from there, we were able to determine the point at which any surgeon learning curve ceased to exert a statistically significant influence. Although this resulted in a specific 'tipping point' of 56/57 grafts, for use in further statistical analyses, it should be acknowledged that for a variety of reasons, such as recipient refusal, some grafts will not be registered with the ACGR. Furthermore, for registered grafts, the definition of graft failure may have varied somewhat amongst different surgeons. Thus, the specificity of this figure should be treated with some flexibility when considering application of the findings to real-world settings.
Previous registry-based studies of the progressive results of a surgical procedure 24, 28, 33 have measured an overall learning curve that failed to take into account an individual surgeon's experience at the time of surgery. The majority of previous research into surgeon learning curves for DSEKs and DSAEKs has focused on the outcomes of consecutive cohorts of grafts performed by a single surgeon, or occasionally a small group of surgeons. 2, 3, 5, 7 Although useful, such data may not be reflective of the experiences of surgeons in different environments, or with different initial skillsets. 8 Our methodology allowed us to consider specific surgeon experience at the time of endokeratoplasty, in addition to examination of outcomes over time, to permit construction of an overall, national learning curve. We were also able to analyse the longitudinal survival of grafts performed by 13 high-volume individual surgeons.
Persistent graft detachment is a leading reason for early failure of endothelial grafts. 5 Furthermore, it has been suggested that increased trauma to the endothelium resulting from the folding and manipulation of the donor lenticule, inherent in the technique, may increase the likelihood of secondary endothelial failure. 4, 7 Although the numbers of detached and primary non-functioning grafts reported on an individual basis were small, we noted that such adverse events continued to occur even in the hands of experienced surgeons who had performed over 100 or 200 grafts.
Our multivariate analysis identified several variables that exerted a significant, independent impact on the longitudinal survival of DSEK/DSAEKs. Eyes to which steroid had been administered in the immediate preoperative period showed better postoperative graft survival than those not so treated. Preoperative steroid may have afforded additional prophylactic protection to the graft, or such eyes may have been monitored more closely. Those eyes that underwent phacoemulsification and intraocular lens insertion at the time of graft also exhibited better survival than those that did not. Possibly, surgeons performing triple procedures may have possessed greater surgical experience: previous research suggests that surgeons take at least 40 operations to become proficient in phacoemulsification. 31 Although the age of the corneal donor was also retained in the multivariate model, there was no consistent change in graft survival based on increased donor age. The possibility that another donor factor, such as endothelial cell count, may have contributed to this result should be explored.
There remain limitations to our methodology. High-volume surgeons all had had prior experience with other forms of keratoplasty. Previous studies have shown that overall surgeon experience in a broad field of surgery may be more important than experience with a specific technique. 8 Although endothelial keratoplasty is a very different procedure to penetrating keratoplasty, prior experience with any form of keratoplasty may diminish the impact of a surgeon learning curve on outcomes for DSEK/DSAEK. It is possible that an analysis focusing on surgical trainees who go on to perform high numbers of endokeratoplasties may reveal different results. Further, Australian ophthalmic surgeons often complete fellowships or training courses in new techniques overseas, for which we would not have information.
Although we refer to surgeons with 57 or more registered DSEKs or DSAEKs as 'high-volume', this classification was based on the tipping point detected in our analyses and is primarily a label used for ease of reference. Such surgeons had typically registered one to five DSEKs or DSAEKs per month over the study period, which in other contexts might not be considered high volume. It would be desirable to apply our new methodology to penetrating keratoplasties, but this is problematic. Many contributors were already experienced in penetrating keratoplasty at the time of inception of the ACGR, and surgeons who have relocated to Australia have often had extensive international experience with this technique.
We previously reported an analysis of the rates of failure of DSEKs and DSAEKs performed by highvolume surgeons, 9 in which we failed to find convincing evidence for a learning curve. Our current findings confirm this result for highly experienced, high-volume surgeons but provide evidence for a learning curve that affects less experienced surgeons.
In conclusion, we found evidence for the existence of a 'national' surgeon learning curve for DSEKs and DSAEKs. Once 56 such grafts had been performed, subsequent graft survival was not affected by further Endothelial keratoplasty learning curve 581
experience. However, we found no evidence of a learning curve for individual, experienced highvolume surgeons who had performed 57 or more DSEKs and/or DSAEKs during the 8-year study period.
